CDD is delighted to be celebrating another achievement. In December 2021, a member of UK based GyreOx Therapeutics made the lucky 3-millionth login to the CDD Vault hosted informatics platform. Romario Ferreira-Pontes recently joined GyreOx in his first role after completing his MChem at The University of Manchester, and has joined the team in using CDD Vault for data […]
Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virusInitial performance results show potentially significant quality, time, and cost advantages compared to traditional chemical synthesis and alternative enzymatic DNA synthesis approaches SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) — […]
Hamburg — Eppendorf and the journal Science are now accepting applications for the 2022 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers who are not older than 35 years […]
CAMBRIDGE, UK – Nuclera, a Cambridge, UK-based biotech company developing cutting-edge benchtop protein printing technologies, announces the opening of its US subsidiary located in Boston, MA. The addition of this new US facility in the rapidly growing biotechnology hub of greater Boston USA is a critical step in the company’s plans and will pave the way […]
Biognosys is the first global proteomics service provider that is GLP certified for preclinical studies and GCP compliant for clinical studies ZURICH – Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that it has obtained Good Laboratory Practice (GLP) certification from Swiss health authorities for preclinical studies. With this certification, […]
Oxford Nanopore worked with a team led by Stanford University School of Medicine in a research study to develop a rapid, whole genome sequencing approach, that: Improves prognosis in critically ill patients and guides clinical management at least as well as current short read technologies. Reduces the time to identify disease-causing genetic variants — to as little […]
BOSTON — TetraScience, the R&D Data Cloud Company, is pleased to share highlights from a record-breaking 2021 fiscal year, including 300% annual recurring revenue (ARR) growth, an $80M Series B funding round, and full operationalization of the Tetra Partner Network. In 2021, TetraScience increased its ARR 3X year-over year, driven by continued rapid adoption of its […]
Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Since study launch, 12 sites across 5 countries have already signed up for participation BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the […]
CUPERTINO, Calif. — Protein Metrics Inc., the market leader in mass spectrometry software for protein characterization, announced today an eighth consecutive year of record growth in bookings and revenue. Adoption by new customers, significant growth in Europe, India, Asia Pacific and the US, and the expansion of enterprise capabilities and deployments into new domains, from discovery to GxP/compliant labs, […]
Investment Will Help Meet Growing Demand for Agilent’s Products in China SANTA CLARA, Calif. — Agilent Technologies (NYSE: A) today announced plans to invest $20 million to expand its Shanghai manufacturing center to meet growing demand in China for the company’s advanced liquid chromatography (LC), spectrometer and mass spectroscopy (MS) systems. “This expansion will […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
